NGS based Diagnostic Service - MomGuard

MomGuard™ [Next generation birth defect screening test]

First non-invasive prenatal test developed in Korea through NGS technology.

Chromosome aneuploidy test using cell-free DNA in maternal blood.

Characteristics of MomGuard

Own development of high quality NIPT pipeline (diagnostics target, accuracy)
Highly efficient and cost effective analysis platform built by applying proprietary ViaTAG technology
Application of proprietary program GeneBro algorithm, 99% accurate analysis system.

MomGuard™ targets

Down syndrome (Trisomy 21)

Edward syndrome (Trisomy 18) 

Patau syndrome (Trisomy 13)

Sex chromosome aneuploidy
(XO, XXY, XXX)